| Product Name | CasNo | Molecular Formula | Purity | Inquiry |
|---|---|---|---|---|
| Pirtobrutinib (LOXO-305) | 2101700-15-4 | C22H21F4N5O3 | 99% | Inquiry |
| Trilaciclib | 1374743-00-6 | C24H30N8O | 99% | Inquiry |
| Binimetinib | 606143-89-9 | C17H15BrF2N4O3 | 99% | Inquiry |
| Pralsetinib | 2097132-94-8 | C27H32FN9O2 | 99% | Inquiry |
| Oxaliplatin | 61825-94-3 | C8H14N2O4Pt | 99% | Inquiry |
| Capivasertib | 1143532-39-1 | C21H25ClN6O2 | 99% | Inquiry |
| Cedazuridine | 1141397-80-9 | C9H14F2N2O5 | 99% | Inquiry |
| Ribociclib | 1211441-98-3 | C23H30N8O | 99% | Inquiry |
| Ixazomib citrate | 1201902-80-8 | C20H23BCl2N2O9 | 99% | Inquiry |
| Midostaurin | 120685-11-2 | C35H30 N4 O4 | 99% | Inquiry |
| Acalabrutinib | 1420477-60-6 | C26H23N7O2 | 99% | Inquiry |
| Adagrasib | 2326521-71-3 | C32H35ClFN7O2 | 99% | Inquiry |
Product Name：Pirtobrutinib (LOXO-305)
CasNo：2101700-15-4
Molecular Formula：C22H21F4N5O3
Purity：99%
InquiryProduct Name：Ixazomib citrate
CasNo：1201902-80-8
Molecular Formula：C20H23BCl2N2O9
Purity：99%
Inquiry
All chemicals are for R&D use only. Controlled products will be followed China law and buyer's country regulation.
